Effect of simultaneous integrated boost intensity-modulated radiation therapy in the treatment of multiple metastasis tumor of brain
10.7683/xxyxyxb.2018.01.013
- VernacularTitle:调强同步推量放射治疗脑多发转移瘤疗效观察
- Author:
Jun YANG
1
;
Ying WANG
;
Xiao WANG
;
Zhuo-Ran LI
;
Xiao-Rui LI
;
Hong-Rui NIU
Author Information
1. 新乡医学院第一附属医院肿瘤科
- Keywords:
simultaneous integrated boost intensity-modulated radiation therapy;
three-dimensional conformal radiation therapy;
multiple metastasis tumor of brain
- From:
Journal of Xinxiang Medical College
2018;35(1):54-56,60
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical effect of simultaneous integrated boost intensity-modulated radiation therapy (SIB-IMRT)and whole brain radiation therapy (WBRT) plus sequential boost conformal radiation therapy (SBCRT) in the treatment of multiple metastasis tumor of brain.Methods A total of 98 patients with multiple metastasis tumor of brain in the Radiation Oncology Center of the First Affiliated Hospital of Xinxiang Medical University from August 2014 to July 2015 were divided into observation group (n =60) and control group (n =38) according to the treatment plan.The patients in the observation group were treated with SIB-IMRT,the whole brain planned target dose was 2 Gy every time,and the target dose of the metastatic target volume was 3 Gy every time for 20 times (5 times weekly).The patients in the control group received WBRT plus SBCRT,the WBRT dose was 3 Gy every time for 10 times(5 times weekly),then the metastatic tumor target area was treated with SBCRT,the prescribed dose was 3 Gy every time for 10 times.All patients were followed up from the end of treatment to December 2016.The effective rate,disease control rate and one-year survival rate were compared between the two groups.Results The patients in the two groups were successfully treated with radiotherapy.Ninety patients were followed up,eight patients were lost to follow-up,the follow-up rate was 91.8％ (90/98).The effective rate,disease control rate and oneyear survival rate in the observation group were significantly higher than those in the control group (x2 =5.371,4.352,6.002;P ＜ 0.05).The median progression free survival time in the observation group was significantly longer than that in the control group (x2 =6.537,P ＜ 0.05).There were no significant differences in the incidence of bone marrow suppression,digestive system reaction and nervous system damage between the two groups (x2 =1.821,2.032,3.782;P ＞ 0.05).Conclusion SIB-IMRT can improve the effective rate,disease control rate and one-year survival rate of patients with multiple metastasis tumor of brain.
